pharmaceuticals

AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues…

TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including…

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022.…

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better…

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday said that Fundamental Research Corp. initiated equity analyst coverage of its stock with…

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q4 2022 Earnings Call dated Mar. 09, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and…

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) released details of discoveries that have potential applications for tumor suppression across multiple…

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Darren Fox -- Executive Director, Investor Relations Bruce…

Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa…

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jonathan Kurtis received a new patent for his…

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Traci McCarty -- Group Vice President of Investor…

The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the…

Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2…

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2022 earnings call dated Feb. 03, 2023 Corporate Participants: Ryan Crowe -- Vice President, Investor Relations…

Cigna Corporation (NYSE: CI) has reported an increase in net income for the fourth quarter of 2022 when the healthcare…

Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) has reported a sharp increase in net profit for the fourth quarter of…

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged…

Eli Lilly and Company (NYSE: LLY) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President…

Eli Lilly and Company (NYSE: LLY) reported fourth quarter 2022 earnings results today. Revenue fell 9% year-over-year to $7.3 billion. Reported…